Again correct me if I am wrong but this would require some degree of fraudulent action taken by the company which there is no evidence and lacks credibility. Any failure of endpoints in addition to having to report these failures to the FDA, the company would have to advise investors of under sec regulations. The company (essentially lawyers) are very well aware of their legal obligations. It is therefore ludicrous to suggest they would risk their personal wealth in this manner.
Market Data 
Markets 
AI
